Literature DB >> 6804083

The immunologic characterization of 40 extranodal lymphoid infiltrates: usefulness in distinguishing between benign pseudolymphoma and malignant lymphoma.

D M Knowles, J P Halper, F A Jakobiec.   

Abstract

In the studies described here, 40 extranodal lymphoid tumors obtained from 38 patients were evaluated by cell-marker analysis and the results correlated with the light microscopic features. These infiltrates were investigated for the present composition of cells expressing Ia antigens, surface immunoglobulin (SIg), including kappa and lambda light chains, sheep erythrocyte (E) rosette formation, and acid a-naphthyl acetate esterase (ANAE) activity. Fifteen biopsy specimens consisted of variable proportions of benign T and polyclonal B cells; these 15 lesions had the histopathologic features of benign pseudolymphomas. The remaining biopsy specimens consisted almost entirely of B cells bearing monoclonal SIg (18 cases) or a great preponderance of T cells (five cases) or non-B, non-T (null) cells (two cases); these 25 lesions were classified histopathologically as malignant lymphomas. Thus, the extranodal lymphoid infiltrates were divisible, according to their cell-marker characteristics, into two categories: lesions that are immunologically polyclonal and lesions that are immunologically monoclonal B-cell proliferations or consist of a great preponderance of T or null cells. In each case, polyclonality correlated with benign cytomorphologic features and monoclonality correlated with malignant histopathology. Cell-marker analysis appears to represent an important adjunct to light microscopy in distinguishing histologically problematic benign pseudolymphomas from malignant lymphomas that arise in the extranodal tissues. Cell marker analysis will undoubtedly provide insights into the histogenesis, natural history, and biologic behavior of the extranodal lymphoid neoplasms not attainable using light microscopy alone.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6804083     DOI: 10.1002/1097-0142(19820601)49:11<2321::aid-cncr2820491120>3.0.co;2-c

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  Gastric pseudolymphoma. Not necessarily a benign lesion.

Authors:  J F Sweeney; C Muus; P P McKeown; A S Rosemurgy
Journal:  Dig Dis Sci       Date:  1992-06       Impact factor: 3.199

2.  Malignant lymphoma of the gastrointestinal tract and mesentery. A clinico-pathologic study of the significance of histologic classification. NHL Study Group of the Comprehensive Cancer Center West.

Authors:  J H van Krieken; R Otter; J Hermans; K van Groningen; P J Spaander; M M van de Sandt; J F Keuning; P M Kluin
Journal:  Am J Pathol       Date:  1989-08       Impact factor: 4.307

3.  Pseudolymphoma of the jejunum.

Authors:  H Gudjonsson; M Jones; E L Krawitt; M D Kaye
Journal:  Dig Dis Sci       Date:  1987-11       Impact factor: 3.199

4.  Immunocytoma of the skin simulating lymphadenosis benigna cutis.

Authors:  S C van der Putte; J Toonstra; H J Schuurman; J A van Unnik
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

5.  A large and massive abdominal venous thrombosis associated with the presence of a big axillary mass, lupus-like syndrome and antiphospholipid antibodies.

Authors:  Elia Ascer; Liv Goldstein Ascer; Magnus Gidlund
Journal:  BMJ Case Rep       Date:  2011-06-29

6.  Clonal rearrangements of immunoglobulin genes and progression to B cell lymphoma in cutaneous lymphoid hyperplasia.

Authors:  G S Wood; B Y Ngan; R Tung; T E Hoffman; E A Abel; R T Hoppe; R A Warnke; M L Cleary; J Sklar
Journal:  Am J Pathol       Date:  1989-07       Impact factor: 4.307

Review 7.  Immunophenotypic and antigen receptor gene rearrangement analysis in T cell neoplasia.

Authors:  D M Knowles
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.